{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:01:41Z","timestamp":1778216501671,"version":"3.51.4"},"reference-count":144,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T00:00:00Z","timestamp":1542844800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02708","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T08:10:39Z","timestamp":1542874239000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Management of Autoimmune Encephalitis: An Observational Monocentric Study of 38 Patients"],"prefix":"10.3389","volume":"9","author":[{"given":"Stefan","family":"Macher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedrich","family":"Zimprich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desiree","family":"De Simoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romana","family":"H\u00f6ftberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulus S.","family":"Rommer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/acn3.328","article-title":"Paraneoplastic cerebellar degeneration with anti-Yo antibodies \u2013 a review","volume":"3","author":"Venkatraman","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"B2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/brain\/91.3.481","article-title":"\u201cLimbic encephalitis\u201d and its association with carcinoma","volume":"91","author":"Corsellis","year":"1968","journal-title":"Brain"},{"key":"B3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/brain\/83.3.357","article-title":"Subacute encephalitis of later adult life. Mainly affecting the limbic areas","volume":"83","author":"Brierley","year":"1960","journal-title":"Brain"},{"key":"B4","first-page":"24","article-title":"[Limbic encephalitis: a probably under-recognized syndrome]","volume":"20","author":"Graus","year":"2005","journal-title":"Neurol Barc Spain"},{"key":"B5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/NRL.0b013e31813e34a5","article-title":"Limbic encephalitis and variants: classification, diagnosis and treatment","volume":"13","author":"T\u00fcz\u00fcn","year":"2007","journal-title":"Neurologist"},{"key":"B6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.17925\/ENR.2013.08.01.31","article-title":"Autoimmune encephalitis","volume":"8","author":"Leypoldt","year":"2013","journal-title":"Eur Neurol Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","article-title":"Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study","volume":"10","author":"Granerod","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"van Swieten","year":"1988","journal-title":"Stroke"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1212\/01.wnl.0000327342.58936.e0","article-title":"Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease","volume":"71","author":"Murinson","year":"2008","journal-title":"Neurology"},{"key":"B10","first-page":"430","article-title":"Expression of an antigen in small cell lung carcinoma lines detected by antibodies from patients with paraneoplastic dorsal root ganglionpathy","volume":"48","author":"Budde-Steffen","year":"1988","journal-title":"Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jneuroim.2015.11.009","article-title":"Pitfalls in the detection of CV2 (CRMP5) antibodies","volume":"290","author":"Sabater","year":"2016","journal-title":"J Neuroimmunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1468-1331.2010.03220.x","article-title":"Screening for tumours in paraneoplastic syndromes: report of an EFNS task force","volume":"18","author":"Titulaer","year":"2011","journal-title":"Eur J Neurol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s00115-018-0499-z","article-title":"[Autoimmune encephalitis with psychotic symptoms : diagnostics, warning signs and practical approach]","volume":"89","author":"Steiner","year":"2018","journal-title":"Nervenarzt"},{"key":"B14","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1001\/jamaneurol.2016.4226","article-title":"Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies","volume":"74","author":"Finke","year":"2017","journal-title":"JAMA Neurol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3174\/ajnr.A5593","article-title":"Brain MRI characteristics of patients with anti-N-methyl-D-aspartate receptor encephalitis and their associations with 2-year clinical outcome","volume":"39","author":"Zhang","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3174\/ajnr.A3633","article-title":"MRI findings in autoimmune voltage-gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis","volume":"35","author":"Kotsenas","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/brain\/awx070","article-title":"Focal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitis","volume":"140","author":"Miller","year":"2017","journal-title":"Brain"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1007\/s00415-010-5604-6","article-title":"Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study","volume":"257","author":"Iizuka","year":"2010","journal-title":"J Neurol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/ene.12249","article-title":"Limbic encephalitis: a clinical-radiological comparison between herpetic and autoimmune etiologies","volume":"20","author":"Oyanguren","year":"2013","journal-title":"Eur J Neurol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/brain\/awh203","article-title":"Clinical analysis of anti-Ma2-associated encephalitis","volume":"127","author":"Dalmau","year":"2004","journal-title":"Brain"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonz\u00e1lez","year":"2014","journal-title":"Brain"},{"key":"B26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.eplepsyres.2011.04.006","article-title":"Extratemporal EEG and MRI findings in ANNA-1 (anti-Hu) encephalitis","volume":"95","author":"Rudzinski","year":"2011","journal-title":"Epilepsy Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1212\/WNL.0b013e318296e9c3","article-title":"Autoimmune limbic encephalopathy and anti-Hu antibodies in children without cancer","volume":"80","author":"Honnorat","year":"2013","journal-title":"Neurology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.seizure.2017.04.005","article-title":"Characteristics of seizure-induced signal changes on MRI in patients with first seizures","volume":"48","author":"Kim","year":"2017","journal-title":"Seizure"},{"key":"B29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1212\/WNL.0b013e3182698cd8","article-title":"Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis","volume":"79","author":"Schmitt","year":"2012","journal-title":"Neurology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.yebeh.2015.04.032","article-title":"EEG extreme delta brush: an ictal pattern in patients with anti-NMDA receptor encephalitis","volume":"49","author":"Veciana","year":"2015","journal-title":"Epilepsy Behav."},{"key":"B32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1055\/s-0033-1337973","article-title":"Neuroimmunologie: Neues zur limbischen Enzephalitis","volume":"40","author":"Pr\u00fc\u00df","year":"2013","journal-title":"Akt Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1212\/WNL.35.4.538","article-title":"Neuronal antinuclear antibody in sensory neuronopathy from lung cancer","volume":"35","author":"Graus","year":"1985","journal-title":"Neurology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/1531-8249(200001)47:1<9::AID-ANA5>3.0.CO;2-I","article-title":"Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration","volume":"47","author":"Albert","year":"2000","journal-title":"Ann Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e27384","DOI":"10.4161\/onci.27384","article-title":"Immunopathogenesis of paraneoplastic neurological syndromes associated with anti-Hu antibodies: a beneficial antitumor immune response going awry","volume":"2","author":"Pignolet","year":"2013","journal-title":"Oncoimmunology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12974-015-0358-9","article-title":"\u2018Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo\/CDR2, anti-Nb\/AP3B2, PCA-2, anti-Tr\/DNER, other antibodies, diagnostic pitfalls, summary and outlook","volume":"12","author":"Jarius","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3988\/jcn.2009.5.3.151","article-title":"Anti-ri-antibody-associated paraneoplastic syndrome in a man with breast cancer showing a reversible pontine lesion on MRI","volume":"5","author":"Kim","year":"2009","journal-title":"J Clin Neurol Seoul Korea"},{"key":"B38","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/cne.22212","article-title":"Differential localization of \u03b3-aminobutyric acid type a and glycine receptor subunits and gephyrin in the human pons, medulla oblongata and uppermost cervical segment of the spinal cord: an immunohistochemical study","volume":"518","author":"Waldvogel","year":"2009","journal-title":"J Comp Neurol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ana.22297","article-title":"Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia","volume":"69","author":"Lancaster","year":"2011","journal-title":"Ann Neurol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1215\/15228517-2006-013","article-title":"Hypersomnia as presenting symptom of anti-Ma2-associated encephalitis: case study","volume":"9","author":"Rojas-Marcos","year":"2007","journal-title":"Neuro Oncol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1212\/01.WNL.0000101718.92619.67","article-title":"Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis","volume":"62","author":"Overeem","year":"2004","journal-title":"Neurology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1136\/jnnp.2010.223271","article-title":"Anti Ma2-associated myeloradiculopathy: expanding the phenotype of anti-Ma2 associated paraneoplastic syndromes","volume":"83","author":"Murphy","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B44","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1136\/jnnp.2005.068775","article-title":"Anti-Ma2 associated paraneoplastic neurological syndrome presenting as encephalitis and progressive muscular atrophy","volume":"77","author":"Waragai","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.nrl.2016.05.010","article-title":"Anti-Ma and anti-Ma2-associated paraneoplastic neurological syndromes","volume":"33","author":"Ortega Suero","year":"2018","journal-title":"Neurol Barc Spain"},{"key":"B46","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/ana.20614","article-title":"Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma","volume":"58","author":"Vitaliani","year":"2005","journal-title":"Ann Neurol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J Neurosci"},{"key":"B49","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann Neurol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/WNL.0b013e3181cb3e52","article-title":"Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor","volume":"74","author":"Bataller","year":"2010","journal-title":"Neurology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.neuron.2013.10.025","article-title":"AMPARs and synaptic plasticity: the last 25 years","volume":"80","author":"Huganir","year":"2013","journal-title":"Neuron"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1212\/WNL.0000000000001682","article-title":"Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients","volume":"84","author":"H\u00f6ftberger","year":"2015","journal-title":"Neurology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nrneurol.2012.99","article-title":"Neuronal autoantigens\u2013pathogenesis, associated disorders and antibody testing","volume":"8","author":"Lancaster","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3988\/jcn.2016.12.1.1","article-title":"The diagnosis and treatment of autoimmune encephalitis","volume":"12","author":"Lancaster","year":"2016","journal-title":"J Clin Neurol Seoul Korea"},{"key":"B55","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nsmb1228","article-title":"GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop","volume":"14","author":"Fenalti","year":"2007","journal-title":"Nat Struct Mol Biol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1471-4159.2006.03741.x","article-title":"Evidence that GAD65 mediates increased GABA synthesis during intense neuronal activity in vivo","volume":"97","author":"Patel","year":"2006","journal-title":"J Neurochem"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Saiz","year":"2008","journal-title":"Brain"},{"key":"B58","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3109\/01658107.2015.1050744","article-title":"Autoimmune-related retinopathy and optic neuropathy accompanied by anti-GAD antibodies","volume":"39","author":"Almarzouqi","year":"2015","journal-title":"Neuro Ophthalmol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10286-016-0390-6","article-title":"Post-ganglionic autonomic neuropathy associated with anti-glutamic acid decarboxylase antibodies","volume":"27","author":"Fileccia","year":"2017","journal-title":"Clin Auton Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3389\/fimmu.2017.00442","article-title":"Hello from the other side: how autoantibodies circumvent the blood-brain barrier in autoimmune encephalitis","volume":"8","author":"Platt","year":"2017","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12311-015-0664-x","article-title":"Consensus paper: neuroimmune mechanisms of cerebellar ataxias","volume":"15","author":"Mitoma","year":"2016","journal-title":"Cerebellum Lond Engl"},{"key":"B62","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jaut.2011.05.005","article-title":"Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies","volume":"37","author":"Ali","year":"2011","journal-title":"J Autoimmun"},{"key":"B63","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/ana.410440209","article-title":"Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome","volume":"44","author":"Dinkel","year":"1998","journal-title":"Ann Neurol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/ana.21123","article-title":"Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases","volume":"61","author":"Manto","year":"2007","journal-title":"Ann Neurol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.4049\/jimmunol.0903728","article-title":"Central nervous system destruction mediated by glutamic acid decarboxylase-specific CD4+ T cells","volume":"184","author":"Burton","year":"2010","journal-title":"J Immunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1046\/j.1365-2249.2002.01931.x","article-title":"T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity","volume":"129","author":"Costa","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.clineuro.2009.06.005","article-title":"Stiff person syndrome associated with lower motor neuron disease and infiltration of cytotoxic T cells in the spinal cord","volume":"111","author":"Holm\u00f8y","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"key":"B68","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.expneurol.2012.10.013","article-title":"Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats","volume":"239","author":"Hansen","year":"2013","journal-title":"Exp Neurol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/S0140-6736(05)66376-3","article-title":"Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin","volume":"365","author":"Sommer","year":"2005","journal-title":"Lancet Lond Engl"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/NEJMoa01167","article-title":"High-dose intravenous immune globulin for stiff-person syndrome","volume":"345","author":"Dalakas","year":"2001","journal-title":"N Engl J Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B72","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1001\/jamaneurol.2015.0749","article-title":"Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies","volume":"72","author":"Ari\u00f1o","year":"2015","journal-title":"JAMA Neurol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12883-015-0435-9","article-title":"Long latency between GAD-antibody detection and development of limbic encephalitis\u2013a case report","volume":"15","author":"Fauser","year":"2015","journal-title":"BMC Neurol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/ana.25002","article-title":"A double-blind, placebo-controlled study of rituximab in patients with stiff person syndrome","volume":"82","author":"Dalakas","year":"2017","journal-title":"Ann Neurol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.4103\/0366-6999.180514","article-title":"Autoimmune encephalitis: an expanding frontier of neuroimmunology","volume":"129","author":"Guan","year":"2016","journal-title":"Chin Med J."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1212\/01.wnl.0000327606.50322.f0","article-title":"Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody","volume":"71","author":"Hutchinson","year":"2008","journal-title":"Neurology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1001\/jamaneurol.2013.574","article-title":"Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype","volume":"70","author":"McKeon","year":"2013","journal-title":"JAMA Neurol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.10279","article-title":"Stiff man syndrome and related conditions","volume":"17","author":"Meinck","year":"2002","journal-title":"Mov Disord"},{"key":"B79","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/brain\/99.1.27","article-title":"Progressive encephalomyelitis with rigidity","volume":"99","author":"Whiteley","year":"1976","journal-title":"Brain"},{"key":"B80","doi-asserted-by":"publisher","first-page":"7568","DOI":"10.1523\/JNEUROSCI.21-19-07568.2001","article-title":"Localization of Caspr2 in myelinated nerves depends on axon-glia interactions and the generation of barriers along the axon","volume":"21","author":"Poliak","year":"2001","journal-title":"J Neurosci"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S0896-6273(00)81049-1","article-title":"Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels","volume":"24","author":"Poliak","year":"1999","journal-title":"Neuron"},{"key":"B82","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/ana.25120","article-title":"Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia","volume":"83","author":"Patterson","year":"2017","journal-title":"Ann Neurol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12974-016-0689-1","article-title":"Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome","volume":"13","author":"Sabater","year":"2016","journal-title":"J Neuroinflammation"},{"key":"B84","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody-associated disease","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1212\/wnl.54.3.771","article-title":"Morvan's syndrome associated with voltage-gated K+ channel antibodies","volume":"54","author":"Barber","year":"2000","journal-title":"Neurology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/WCO.0000000000000444","article-title":"Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies)","volume":"30","author":"Bastiaansen","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/ene.13180","article-title":"Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome","volume":"24","author":"Bien","year":"2017","journal-title":"Eur J Neurol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1007\/s00115-018-0501-9","article-title":"[Principles of autoimmune and paraneoplastic encephalitis]","volume":"89","author":"Bien","year":"2018","journal-title":"Nervenarzt"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e4244","DOI":"10.1097\/MD.0000000000004244","article-title":"Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures","volume":"95","author":"Li","year":"2016","journal-title":"Medicine"},{"key":"B90","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/ana.10713","article-title":"Voltage-gated potassium channel antibodies in limbic encephalitis","volume":"54","author":"Pozo-Rosich","year":"2003","journal-title":"Ann Neurol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1136\/jnnp.2006.102467","article-title":"Paraneoplastic limbic encephalitis associated with potassium channel antibodies: value of anti-glial nuclear antibodies in identifying the tumour","volume":"78","author":"Zuliani","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B92","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","article-title":"The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis","volume":"13","author":"van Sonderen","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1212\/WNL.0000000000004541","article-title":"Antibody-associated CNS syndromes without signs of inflammation in the elderly","volume":"89","author":"Escudero","year":"2017","journal-title":"Neurology"},{"key":"B94","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann. Neurol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1093\/brain\/awt212","article-title":"Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype","volume":"136","author":"Irani","year":"2013","journal-title":"Brain"},{"key":"B96","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/jamaneurol.2014.463","article-title":"Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy","volume":"71","author":"Irani","year":"2014","journal-title":"JAMA Neurol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00415-014-7408-6","article-title":"Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity","volume":"261","author":"Malter","year":"2014","journal-title":"J Neurol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","article-title":"Neuropathological criteria of anti-IgLON5-related tauopathy","volume":"132","author":"Gelpi","year":"2016","journal-title":"Acta Neuropathol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/S1474-4422(14)70157-7","article-title":"Sleep disorder associated with antibodies to IgLON5: parasomnia or agrypnia?-Authors' reply","volume":"13","author":"Gaig","year":"2014","journal-title":"Lancet Neurol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e393","DOI":"10.1212\/NXI.0000000000000393","article-title":"Understanding anti-IgLON5 disease","volume":"4","author":"Graus","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","article-title":"Clinical manifestations of the anti-IgLON5 disease","volume":"88","author":"Gaig","year":"2017","journal-title":"Neurology"},{"key":"B103","doi-asserted-by":"publisher","first-page":"e385","DOI":"10.1212\/NXI.0000000000000385","article-title":"IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients","volume":"4","author":"Honorat","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"B104","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0140-6736(66)92876-5","article-title":"Hashimoto's disease and encephalopathy","volume":"2","author":"Brain","year":"1966","journal-title":"Lancet Lond Engl"},{"key":"B105","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jns.2003.09.007","article-title":"Hashimoto's encephalopathy: epidemiologic data and pathogenetic considerations","volume":"217","author":"Ferracci","year":"2004","journal-title":"J Neurol Sci"},{"key":"B106","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jns.2013.05.009","article-title":"Diagnostic and therapeutic aspects of Hashimoto's encephalopathy","volume":"331","author":"Olmez","year":"2013","journal-title":"J Neurol Sci"},{"key":"B107","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/archneur.63.2.197","article-title":"Steroid-responsive encephalopathy associated with autoimmune thyroiditis","volume":"63","author":"Castillo","year":"2006","journal-title":"Arch Neurol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.autrev.2016.09.008","article-title":"Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): characteristics, treatment and outcome in 251 cases from the literature","volume":"15","author":"Laurent","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B109","first-page":"55","article-title":"[Hashimoto's encephalopathy. Case report and literature review]","volume":"38","author":"Jamrozik","year":"2004","journal-title":"Neurol Neurochir Pol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"B111","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jneuroim.2007.08.012","article-title":"Anti-thyroperoxidase antibodies from patients with Hashimoto's encephalopathy bind to cerebellar astrocytes","volume":"192","author":"Blanchin","year":"2007","journal-title":"J Neuroimmunol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/cei.12185","article-title":"Paraneoplastic neurological syndromes","volume":"175","author":"Leypoldt","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"e1260212","DOI":"10.1080\/2162402X.2016.1260212","article-title":"CD4+ and CD8+ T cells are both needed to induce paraneoplastic neurological disease in a mouse model","volume":"6","author":"Gebauer","year":"2016","journal-title":"Oncoimmunology"},{"key":"B114","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3389\/fneur.2018.00706","article-title":"Systematic review: syndromes, early diagnosis, and treatment in autoimmune encephalitis","volume":"9","author":"Hermetter","year":"2018","journal-title":"Front Neurol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e413","DOI":"10.1212\/NXI.0000000000000413","article-title":"Decreased occipital lobe metabolism by FDG-PET\/CT: an anti-NMDA receptor encephalitis biomarker","volume":"5","author":"Probasco","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"B116","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00234-017-1956-2","article-title":"Metabolic topography of autoimmune non-paraneoplastic encephalitis","volume":"60","author":"Tripathi","year":"2018","journal-title":"Neuroradiology"},{"key":"B117","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1212\/NXI.0000000000000386","article-title":"Frequencies of neuronal autoantibodies in healthy controls: estimation of disease specificity","volume":"4","author":"Lang","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"B118","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.schres.2017.03.012","article-title":"Seroprevalence survey of selective anti-neuronal autoantibodies in patients with first-episode schizophrenia and chronic schizophrenia","volume":"190","author":"Chen","year":"2017","journal-title":"Schizophr Res"},{"key":"B119","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.schres.2017.04.027","article-title":"Anti-neuronal anti-bodies in patients with early psychosis","volume":"192","author":"Mantere","year":"2017","journal-title":"Schizophr Res."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1001\/jamaneurol.2013.3216","article-title":"Frequency and characteristics of isolated psychiatric episodes in anti\u2013N-methyl-d-aspartate receptor encephalitis","volume":"70","author":"Kayser","year":"2013","journal-title":"JAMA Neurol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00406-014-0493-9","article-title":"Seroprevalence of N-methyl-D-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patients","volume":"264","author":"Busse","year":"2014","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"B122","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/ene.12942","article-title":"Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis","volume":"23","author":"Constantinescu","year":"2016","journal-title":"Eur J Neurol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"e458","DOI":"10.1212\/NXI.0000000000000458","article-title":"Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infection","volume":"5","author":"Salovin","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.04.007","article-title":"Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systemic review and meta-analysis","author":"Rupprecht","year":"2018","journal-title":"Clin Microbiol Infect."},{"key":"B125","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/jamaneurol.2014.2956","article-title":"Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response","volume":"72","author":"Leypoldt","year":"2015","journal-title":"JAMA Neurol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fpsyt.2017.00025","article-title":"Red flags: clinical signs for identifying autoimmune encephalitis in psychiatric patients","volume":"8","author":"Herken","year":"2017","journal-title":"Front Psychiatry"},{"key":"B127","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1212\/NXI.0000000000000383","article-title":"IgLON5 disease responsive to immunotherapy","volume":"4","author":"Bonello","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"B128","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jneuroim.2016.09.012","article-title":"Chorea and parkinsonism associated with autoantibodies to IgLON5 and responsive to immunotherapy","volume":"300","author":"Haitao","year":"2016","journal-title":"J Neuroimmunol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1212\/01.wnl.0000237558.83349.d0","article-title":"Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies","volume":"67","author":"Rakocevic","year":"2006","journal-title":"Neurology"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1001\/jamaneurol.2015.2378","article-title":"Responses to and outcomes of treatment of autoimmune cerebellar ataxia in adults","volume":"72","author":"Jones","year":"2015","journal-title":"JAMA Neurol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/nyas.12553","article-title":"Autoimmune encephalopathies","volume":"1338","author":"Leypoldt","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"B132","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1212\/WNL.0000000000000131","article-title":"Seizures as first symptom of anti-NMDA receptor encephalitis are more common in men","volume":"82","author":"Titulaer","year":"2014","journal-title":"Neurology"},{"key":"B133","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.seizure.2014.04.013","article-title":"Pilomotor seizures: an autonomic semiology of limbic encephalitis?","volume":"23","author":"Rocamora","year":"2014","journal-title":"Seizure"},{"key":"B134","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/aogs.12386","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis: have you checked the ovaries?","volume":"93","author":"Cleverly","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B135","first-page":"19","article-title":"Severe anti NMDA encephalitis and EBV infection","volume":"17","author":"Derksen","year":"2013","journal-title":"Netherlands J Crit Care"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1001\/jamaneurol.2016.2588","article-title":"Bortezomib treatment for patients with anti-N-methyl-d-aspartate receptor encephalitis","volume":"73","author":"Behrendt","year":"2016","journal-title":"JAMA Neurol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jneuroim.2017.08.011","article-title":"Successful combined targeting of B- and plasma cells in treatment refractory anti-NMDAR encephalitis","volume":"312","author":"Sveinsson","year":"2017","journal-title":"J Neuroimmunol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1212\/WNL.0000000000003536","article-title":"Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis","volume":"88","author":"Scheibe","year":"2017","journal-title":"Neurology"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1756285617722347","article-title":"Treatment strategies for autoimmune encephalitis","volume":"11","author":"Shin","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"B140","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s13311-016-0442-6","article-title":"Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort study","volume":"13","author":"Lee","year":"2016","journal-title":"Neurother J Am Soc Exp Neurother"},{"key":"B141","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.seizure.2015.05.017","article-title":"Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies","volume":"30","author":"Malter","year":"2015","journal-title":"Seizure"},{"key":"B142","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1001\/jamaneurol.2014.1817","article-title":"Severe cognitive impairment associated with intrathecal antibodies to the NR1 subunit of the N-methyl-D-aspartate receptor in a patient with multiple sclerosis","volume":"72","author":"Fleischmann","year":"2015","journal-title":"JAMA Neurol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"366","author":"Bloomgren","year":"2012","journal-title":"N Engl J Med"},{"key":"B144","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1474-4422(17)30282-X","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies","volume":"16","author":"Ho","year":"2017","journal-title":"Lancet Neurol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02708\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T08:10:43Z","timestamp":1542874243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02708\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,22]]},"references-count":144,"alternative-id":["10.3389\/fimmu.2018.02708"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02708","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,22]]},"article-number":"2708"}}